ApprovalTrail

Ingredient

Prednisolone Sodium Phosphate

Products in Health Canada’s databases that list Prednisolone Sodium Phosphate as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.

Drug products
11
2 authorized now
Natural health products
0
0 active licences
Notices of Compliance
16
Products in all
11

Drug products

Authorized products first.

NameDINStatus
MINIMS PREDNISOLONE SODIUM PHOSPHATE (0.5 %)Bausch & Lomb Inc. · Status since Jan 202302148498Marketed
PMS-PREDNISOLONE SODIUM PHOSPHATE OPHTHALMIC SOLUTION FORTE (1 %)Pharmascience Inc. · Status since Aug 201701954237Dormant
INFLAMASE FORTE OPH SOLN 1% (10 MG)Iolab Pharmaceuticals · Status since Sep 199600756164Cancelled Post Market
INFLAMASE FORTE OPHTHALMIC SOLUTION 1% (1 %)Novartis Ophthalmics Novartis Pharmaceuticals (Canada) Inc · Status since Jul 200402133318Cancelled Post Market
INFLAMASE MILD (.125 %)Novartis Ophthalmics Novartis Pharmaceuticals (Canada) Inc · Status since Jul 200202133296Cancelled Post Market
INFLAMASE OPH SOLN 0.125% (1.25 MG)Iolab Pharmaceuticals · Status since Sep 199600756172Cancelled Post Market
PREDNISOLONE SODIUM PHOSPHATE 1% FORTE (1 %)Rivex Ophthalmics Inc. · Status since Jul 200302213079Cancelled Post Market
R.O.-PREDPHATE TM FORTE (1 %)Richmond Pharmaceuticals Inc. · Status since Aug 199701924400Cancelled Post Market
SAB-PREDNASE (1 %)Sabex Inc. · Status since Aug 201902245858Cancelled Pre Market
VASOCIDIN OPHTHALMIC SOLUTION (2.5 MG)Iolab Pharmaceuticals · Status since Sep 199600843741Cancelled Post Market
VASOCIDIN OPHTHALMIC SOLUTION (2.5 MG)Novartis Ophthalmics Novartis Pharmaceuticals (Canada) Inc · Status since Mar 200402133342Cancelled Post Market

Notices of Compliance

Approvals of drug submissions that list it, newest first.